Chen D-P, Tseng C-P, Wang W-T, Sun C-F
Department of Clinical Pathology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Vox Sang. 2005 Apr;88(3):196-9. doi: 10.1111/j.1423-0410.2005.00608.x.
The A2 is a very rare phenotype in the ABO blood group system in the Oriental population. It corresponds to a special ABO allele encoding a glycosyltransferase that is capable of synthesizing A2 antigens, which is weaker than the typical A antigen. In this study, we report a novel A2 allele in two unrelated Taiwanese individuals.
Two individuals were identified as the A2 phenotype based on the standard ABO serological test. For analysing the A2 allele, both direct sequencing and gene cloning of the ABO gene were performed.
The ABO gene of the two A2 individuals was composed of O1 and A2 alleles, and the novel A2 allele has a 539G > C that results in the amino acid change Arg180Pro. The mutation was not detected in the general group A population.
We report for the first time that a 539G > C mutation represents a new molecular basis for the A2 blood type. The amino acid substitution from arginine to proline may have effect on the expression of A antigen.
A2型在东方人群的ABO血型系统中是一种非常罕见的表型。它对应一种特殊的ABO等位基因,该等位基因编码一种能够合成A2抗原的糖基转移酶,A2抗原比典型的A抗原弱。在本研究中,我们报告了两名无血缘关系的台湾个体中存在一种新的A2等位基因。
根据标准的ABO血清学检测,两名个体被鉴定为A2表型。为分析A2等位基因,对ABO基因进行了直接测序和基因克隆。
两名A2个体的ABO基因由O1和A2等位基因组成,新的A2等位基因存在539G>C突变,导致氨基酸由精氨酸变为脯氨酸。在普通A型人群中未检测到该突变。
我们首次报道539G>C突变是A2血型的一种新的分子基础。从精氨酸到脯氨酸的氨基酸取代可能会影响A抗原的表达。